skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: tipo de recurso: Newsletter Articles remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
New Data from University of Naples Illuminate Research in Remdesivir (Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab)
New Data from University of Naples Illuminate Research in Remdesivir (Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

New Data from University of Naples Illuminate Research in Remdesivir (Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab)

Medical Letter on the CDC & FDA, 2024, p.321

NewsRX LLC

Texto completo disponível

Citações Citado por
2
Department of Medicine IV Researchers Add New Study Findings to Research in COVID-19 (SARS-CoV-2 Pre-Exposure Prophylaxis with Sotrovimab and Tixagevimab/Cilgavimab in Immunocompromised Patients-A Single-Center Experience)
Department of Medicine IV Researchers Add New Study Findings to Research in COVID-19 (SARS-CoV-2 Pre-Exposure Prophylaxis with Sotrovimab and Tixagevimab/Cilgavimab in Immunocompromised Patients-A Single-Center Experience)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Department of Medicine IV Researchers Add New Study Findings to Research in COVID-19 (SARS-CoV-2 Pre-Exposure Prophylaxis with Sotrovimab and Tixagevimab/Cilgavimab in Immunocompromised Patients-A Single-Center Experience)

Medical Letter on the CDC & FDA, 2022, p.258

NewsRX LLC

Texto completo disponível

Citações Citado por
3
Research from University of Campania Has Provided New Data on Empyema (Application of ERAS Protocol after VATS Surgery for Chronic Empyema in Immunocompromised Patients)
Research from University of Campania Has Provided New Data on Empyema (Application of ERAS Protocol after VATS Surgery for Chronic Empyema in Immunocompromised Patients)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Research from University of Campania Has Provided New Data on Empyema (Application of ERAS Protocol after VATS Surgery for Chronic Empyema in Immunocompromised Patients)

Health & Medicine Week, 2022, p.994

NewsRX LLC

Texto completo disponível

Citações Citado por
4
Researchers from Mayo Clinic Describe Findings in Health and Medicine (Utility of Transbronchial Biopsy In the Immunocompromised Host With New Pulmonary Radiographic Abnormalities)
Researchers from Mayo Clinic Describe Findings in Health and Medicine (Utility of Transbronchial Biopsy In the Immunocompromised Host With New Pulmonary Radiographic Abnormalities)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Researchers from Mayo Clinic Describe Findings in Health and Medicine (Utility of Transbronchial Biopsy In the Immunocompromised Host With New Pulmonary Radiographic Abnormalities)

Health & Medicine Week, 2021, p.5784

NewsRX LLC

Texto completo disponível

Citações Citado por
5
New Pneumonia Research from Department of Geriatrics Outlined (Diagnostic Value of Metagenomic Next-Generation Sequencing for Pneumonia in Immunocompromised Patients)
New Pneumonia Research from Department of Geriatrics Outlined (Diagnostic Value of Metagenomic Next-Generation Sequencing for Pneumonia in Immunocompromised Patients)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

New Pneumonia Research from Department of Geriatrics Outlined (Diagnostic Value of Metagenomic Next-Generation Sequencing for Pneumonia in Immunocompromised Patients)

Health & Medicine Week, 2022, p.3756

NewsRX LLC

Texto completo disponível

Citações Citado por
6
University Hospital Dusseldorf Researcher Reports on Findings in Remdesivir (Rapid selection of sotrovimab escape variants in SARS-CoV-2 Omicron infected immunocompromised patients)
University Hospital Dusseldorf Researcher Reports on Findings in Remdesivir (Rapid selection of sotrovimab escape variants in SARS-CoV-2 Omicron infected immunocompromised patients)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

University Hospital Dusseldorf Researcher Reports on Findings in Remdesivir (Rapid selection of sotrovimab escape variants in SARS-CoV-2 Omicron infected immunocompromised patients)

Respiratory Therapeutics Week, 2022, p.1073

NewsRX LLC

Texto completo disponível

Citações Citado por
7
Findings from American Red Cross in the Area of COVID-19 Described (Lessons Learned From the Use of Convalescent Plasma for the Treatment of Covid-19 and Specific Considerations for Immunocompromised Patients)
Findings from American Red Cross in the Area of COVID-19 Described (Lessons Learned From the Use of Convalescent Plasma for the Treatment of Covid-19 and Specific Considerations for Immunocompromised Patients)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Findings from American Red Cross in the Area of COVID-19 Described (Lessons Learned From the Use of Convalescent Plasma for the Treatment of Covid-19 and Specific Considerations for Immunocompromised Patients)

Medical Letter on the CDC & FDA, 2022, p.174

NewsRX LLC

Texto completo disponível

Citações Citado por
8
Immunocompromised patients and COVID infections: Who's at risk?
Immunocompromised patients and COVID infections: Who's at risk?
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Immunocompromised patients and COVID infections: Who's at risk?

Medical Letter on the CDC & FDA, 2024, p.714

NewsRX LLC

Texto completo disponível

Citações Citado por
9
Researchers from Tanta University Describe Findings in COVID-19
Researchers from Tanta University Describe Findings in COVID-19
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Researchers from Tanta University Describe Findings in COVID-19

Medical Letter on the CDC & FDA, 2024, p.466

NewsRX LLC

Texto completo disponível

Citações Citado por
10
University Hospital Researchers Update Understanding of Remdesivir (Outcomes of targeted treatment in immunocompromised patients with asymptomatic or mild COVID-19: a retrospective study)
University Hospital Researchers Update Understanding of Remdesivir (Outcomes of targeted treatment in immunocompromised patients with asymptomatic or mild COVID-19: a retrospective study)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

University Hospital Researchers Update Understanding of Remdesivir (Outcomes of targeted treatment in immunocompromised patients with asymptomatic or mild COVID-19: a retrospective study)

Respiratory Therapeutics Week, 2023, p.717

NewsRX LLC

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.